AngioDynamics, Inc. (ANGO) Total liabilities 2017–2026
AngioDynamics, Inc. (ANGO) total liabilities at each fiscal year-end, per SEC filings.
$96.3MFY2026 · since FY2017: $192.9M → $96.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $96.3M | -0.9% |
| FY2025 | $97.2M | -13.3% |
| FY2024 | $112.1M | -27.4% |
| FY2023 | $154.3M | +20.3% |
| FY2022 | $128.3M | +5.1% |
| FY2021 | $122.0M | -12.5% |
| FY2020 | $139.3M | -37.1% |
| FY2019 | $221.6M | +36.1% |
| FY2018 | $162.9M | -15.6% |
| FY2017 | $192.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Net marginANGO Gross profitANGO Gross marginANGO Operating incomeANGO Operating marginANGO Operating cash flowANGO Free cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Shareholders’ equityANGO overview →